Hexahydrocannabinol (HHC) use and harms in Ireland: New findings from the 2024 European Web Survey on Drugs
These data suggest that HHC has become a prominent feature of the Irish drug landscape. Given its harm potential, it will be important to monitor HHC use and related health harms.
Authors
- Brian Galvin (ORCID: https://orcid.org/0000-0002-5639-1819)
- Seán Millar (ORCID: https://orcid.org/0000-0003-4453-8446)
- João Matias (ORCID: https://orcid.org/0000-0002-2020-8824)
- N. E. B. Killeen (ORCID: https://orcid.org/0000-0001-6220-1586)
- Eamon Keenan (ORCID: https://orcid.org/0000-0002-3395-3831)
- Deirdre Mongan (ORCID: https://orcid.org/0000-0003-3616-4253)
Institutions
- European Medicines Agency (NL)
- European Union (BE)
- University College Cork (IE)
- Health Service Executive (IE)
- Health Research Board (IE)
Publication Details
- Journal
- International Journal of Drug Policy
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.drugpo.2025.105011
- Citations
- 1
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39